What was Fortis Healthcare's revenue in Q3 FY26?

Fortis Healthcare reported revenue of ₹2,265 Cr in Q3 FY26, a +17.5% change year-over-year.

Did Fortis Healthcare management deliver on previous promises?

Scorecard data is being built as historical quarters are processed.

FORTISHEALTHCARE Healthcare 30 Jan 2026

Fortis Healthcare Ltd — Q3 FY26

Q: What guidance did Fortis Healthcare management give?

Brownfield bed addition of ~400 beds in FY27: Major contribution from fMRI expansion (200+ beds) to be commissioned in phases starting April 2026.

Fortis Healthcare delivered a strong Q3 FY26 with consolidated revenue of ₹2,265 crore (+17.5% YoY) and EBITDA margin expansion of 290 bps to 22.3%, driven by hospital business growth of 19.4% and diagnostics margin recovery to 23.1%.

Revenue ₹2,265 Cr +17.5%

EBITDA ₹505 Cr +34.8%

PAT ₹197 Cr -21.2%

EBITDA Margin 22.3% +290bps

Duration 60 min

Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Fortis Healthcare delivered a strong Q3 FY26 with consolidated revenue of ₹2,265 crore (+17.5% YoY) and EBITDA margin expansion of 290 bps to 22.3%, driven by hospital business growth of 19.4% and diagnostics margin recovery to 23.1%. PAT declined to ₹197 crore due to a one-off expense of ₹55 crore for new labor codes. Hospital occupancy remained steady at 67%, while ARPOB grew 4.5% to ₹2.56 lakh, supported by a 52% surge in robotic surgeries. The diagnostics business saw 8.3% revenue growth and a 870 bps margin improvement. Management guided for continued growth trajectory with brownfield expansion of ~400 beds in FY27, led by the fMRI facility. The People Tree acquisition in Bengaluru adds 125 beds with expansion potential to 300. Risks include integration challenges at Glenagles and potential dilution from IHH's planned equity infusion.

Risks4 trackedTranscriptfull text

Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Glenagles integration challenges

View Risks →

≡Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Hospital Occupancy 67%

Flat YoY

Occupancy steady despite 14% increase in occupied beds to 3,189.

ARPOB ₹2.56 lakh

+4.5% YoY

Growth driven by case mix shift to complex procedures, including 52% rise in robotic surgeries.

Diagnostics Volume 9.9M tests

+3.6% YoY

Volume growth supported by network expansion of 175 touch points in Q3.

Bed Addition (9M FY26) 750 beds

+500 beds via M&A, +250 organic

Includes People Tree acquisition (125 beds) and brownfield expansions at Manesar, Noida, Faridabad.

Fast read

Guidance and risk preview

Top guidance Brownfield bed addition of ~400 beds in FY27

Major contribution from fMRI expansion (200+ beds) to be commissioned in phases starting April 2026.

Top risk Glenagles integration challenges

Revenue declined 4% in 9M FY26 due to management changes and operational issues; turnaround expected only from next fiscal.

View Risks →